Covid Vaccine

Covaxin, Covishield mixing: Cocktail vaccine safe, provides better immunity against Covid-19 variants | ICMR study

Covaxin, Covishield mixing: Cocktail vaccine safe, provides better immunity against Covid-19 variants | ICMR study

The Indian Council of Medical Research (ICMR) on Sunday said a study conducted by it on mixing and matching COVID-19 vaccines, Covaxin and Covishield demonstrated better results in building immunity against the coronavirus. Carried out between May and June this year in Uttar Pradesh, the study suggests that iummunisation with combination of an adenovirus vector platform-based vaccine followed by inactivated whole virus vaccine was not only safe but also elicited better immunogenicity. "Such mixed regimens will also help to overcome the challenges of shortfall of particular vaccines and remove hesitancy around vaccines in people's mind that could have genesis in…
Read More
India sees single-day rise of 38,628 Covid-19 cases, 617 deaths

India sees single-day rise of 38,628 Covid-19 cases, 617 deaths

India recorded a single-day rise of 38,628 new coronavirus cases, taking the infection tally to 3,18,95,385, while the death toll climbed to 4,27,371 with 617 fresh fatalities, the Union health ministry said on Saturday. The active cases in the country have declined to 4,12,153 and comprise 1.29 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 97.37 per cent, the ministry data updated at 8 am showed.A decrease of 2,006 cases has been recorded in the active COVID-19 caseload in a span of 24 hours, it said. The ministry also said that 17,50,081 tests…
Read More
J&J’s single-dose Covid vaccine gets Emergency Use approval in India

J&J’s single-dose Covid vaccine gets Emergency Use approval in India

Johnson & Johnson’s single-dose Covid-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said on Saturday. He said this will further boost the country’s collective fight against the novel coronavirus infection. “India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has five EUA vaccines. This will further boost our nation’s collective fight against #COVID19,” the minister tweeted. “The US-based pharmaceutical company had applied for Emergency Use Authorisation for its jab on Friday and was granted the approval the same day by the…
Read More
Johnson & Johnson applies for emergency use authorisation of its single-dose Covid-19 vaccine in India

Johnson & Johnson applies for emergency use authorisation of its single-dose Covid-19 vaccine in India

Global healthcare major Johnson & Johnson today said it has applied for Emergency Use Authorisation (EUA) of its single-dose COVID-19 vaccine in India.On Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021, Johnson & Johnson Pvt. Ltd applied for Emergency Use Authorisation (EUA) of its single-dose covid-19 vaccine to the Government of India," read the statement. Johnson & Johnson claimed that its single-shot vaccine, in clinical trials, proved to be 85 per cent effective in preventing severe disease.…
Read More
SpiceHealth’s mobile testing laboratory in Guwahati

SpiceHealth’s mobile testing laboratory in Guwahati

To conduct Real-Time Polymerase Chain Reaction (RT-PCR) and Rapid Antigen tests, SpiceHealth has launched its first mobile testing laboratory in Guwahati. The Company’s mobile lab will be stationed at the Indira Gandhi Athletic Stadium whereas the sample collection set-up will be at Lokpriya Gopinath Bordoloi International Airport. SpiceHealth has partnered with National Health Mission, Assam to set-up the facility in Guwahati. SpiceHealth operates 23 labs and collection centers spread across ten cities in India. The Company operates seven vaccination centers in five states. SpiceHealth has emerged as the fastest growing diagnostic lab in the country having conducted 3.5 million RT-PCR…
Read More
Over 3.8 Lakh People Without Photo ID Documents Vaccinated Through Co-WIN

Over 3.8 Lakh People Without Photo ID Documents Vaccinated Through Co-WIN

As many as 3.83 lakh people without any photo ID documents have been vaccinated through Co-WIN till July 26, Minister of State for Health Bharati Pravin Pawar said on Friday. All beneficiaries who have received vaccines in India are registered on the Co-WIN portal, she said in a written reply to a question in Lok Sabha “As of 26th July 2021, a total of 3.83 lakh persons without any photo ID documents have been vaccinated through Co-WIN,” she said. The Centre has issued a Standard Operating Procedure (SOP) to facilitate vaccination of eligible beneficiaries who do not possess the prescribed photo…
Read More
Mamata meets PM Modi: More vaccine for the state, Bengal name change discussed

Mamata meets PM Modi: More vaccine for the state, Bengal name change discussed

West Bengal Chief Minister Mamata Banerjee on Tuesday met Prime Minister Narendra Modi. Earlier in the day, she had met Congress leaders Kamal Nath and Anand Sharma and is also likely to meet Sonia Gandhi on Wednesday. Mamata arrived in Delhi on Monday on her first visit to the national capital after assuming office for the third term.  Speaking to the reporters after the meet, the CM said that she has urged the PM for more Covid vaccines for West Bengal. “It was a courtesy meeting with PM today. During the meeting, I raised the issue of COVID & the…
Read More
Children will get Covid vaccine from August , said Health Minister Mansukh Mandaviya

Children will get Covid vaccine from August , said Health Minister Mansukh Mandaviya

On Tuesday, Union Health Minister Mansukh Mandaviya said the Covid-19 vaccine for children is expected to be launched in the country from August. Last week, All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria said the trials for covaxin were underway and the results were expected by September. But curently Covaxin trials are underway on children aged 2-6 years in Delhi AIIMS. Mandaviya also said that India is soon going to be largest vaccine-producing country as more companies will get the production licence. On June 7, Delhi AIIMS started screening children between the age of 2 to 17 for…
Read More
At 29K, India records lowest new Covid cases in 132 days

At 29K, India records lowest new Covid cases in 132 days

India on Tuesday recorded 29,689 new Covid-19 cases, less than the 30,000-mark in 132 days, and 415 deaths, the Ministry of Health and Family Welfare data showed. After 124 days, the country now has 3,08,100 active cases which is less than the four lakh-mark. On March 14, India recorded 26,291 and on March 16, 28,903 new cases. The total number of deaths has reached 4,21,382 as per the government data. According to the government, 42,363 people were discharged from hospitals and health centres in the last 24 hours, taking the total number of cured to 3,06,21,469 till date as the…
Read More
NSE Foundation in partnership with NITI Aayog and UNICEF

NSE Foundation in partnership with NITI Aayog and UNICEF

NSE Foundation, a Section 8 subsidiary of National Stock Exchange of India Limited, has launched an innovative programme that will unite the efforts of grass root level partners and the local district administration to facilitate increased vaccination in remote ‘aspirational’ districts of India which include Nandurbar and Osmanabad in Maharashtra, Karauli in Rajasthan, Ramanathapuram in Tamil Nadu and Kiphire in Nagaland. Dr Vinod K. Paul, Member NITI Aayog, Chair of the Empowered Group on Medical Infrastructure and Covid Management Plan, National Task Force on Covid-19 (ICMR), and the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) launched Project CAVACH…
Read More